Dow closes 700 points lower due to tariff and inflation uncertainties
The US stock market faced a significant decline due to uncertainty over trade policy and a gloomier outlook on inflation.
Weekly Bulletin - World
US stock market faces tests with tariffs and employment data
The market is anxious about Trump's tariff decision and the jobs report, which could influence the economy.
OECD warns that trade fragmentation could slow growth
Uncertainty in trade policies and inflation are among the key risks to global economic growth.
S&P 500 drops 5.12% in 2025
The index is struggling due to uncertainties over tariffs and inflation.
Bitcoin falls over 3% amid concerns over Trump's tariffs
The cryptocurrency market was also affected by political and economic uncertainties.
Dollar Tree leads S&P 500 gains after Family Dollar sale announcement
Dollar Tree's stock surged significantly following the strategic announcement.
AutoZone and O'Reilly Automotive gain from possible tariffs on imported cars
Shares of auto parts suppliers rose as consumers are expected to keep their vehicles longer.
CoreWeave debuts on Nasdaq at $39 per share
The technology company successfully conducted its initial public offering.
Rocket Lab and Braze perform well in the market
Shares of Rocket Lab and Braze rose after positive announcements about contracts and financial results.
Lululemon drops after disappointing forecasts for 2025
The sportswear company saw its shares decline due to expectations of lower consumer spending.
Top Gainers
- OSR Holdings, Inc. (OSRH): Up 136.88%, driven by a significant increase in investor interest, possibly fueled by positive news or speculations about the company's future.
- Lytus Technologies Holdings PTV. Ltd. (LYT): Up 91.49%, possibly due to announcements or positive financial results that attracted investors.
- Greenland Technologies Holding Corporation (GTEC): Up 70.92%, reflecting increased investor interest in green technologies and industry innovations.
- 23andMe Holding Co. (ME): Up 56.06%, possibly due to advancements in genetic testing or strategic partnerships that boosted investor confidence.
- Nkarta, Inc. (NKTX): Up 48.91%, possibly driven by progress in research or the development of new treatments that generated optimism among investors.
Top Losers
- Gesher Acquisition Corp. II (GSHR): Down 96.76%, possibly due to a failed merger or significant financial issues that affected investor confidence.
- Acrivon Therapeutics, Inc. (ACRV): Down 53.06%, possibly due to disappointing clinical trial results or regulatory issues that negatively impacted the company.
- LogProstyle Inc. (LGPS): Down 52.70%, reflecting a loss of investor confidence, possibly due to poor financial performance or market changes.
- Benson Hill, Inc. (BHIL): Down 41.19%, possibly due to challenges in the agricultural sector or operational issues that affected the company's profitability.
- Impact BioMedical Inc. (IBO): Down 37.11%, possibly due to financial problems or underperformance, leading to a loss of investor confidence.
